Incontinence Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Incontinence Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Incontinence Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Incontinence devices are externally or internally worn devices intended to protect the skin from the involuntary loss of urine.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Incontinence Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Incontinence Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Incontinence Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Incontinence Devices Overview
Products under Development
Incontinence Devices - Pipeline Products by Stage of Development
Table Figure1: Incontinence Devices - Pipeline Products by Stage of Development
Table Incontinence Devices - Pipeline Products by Stage of Development
Incontinence Devices - Pipeline Products by Segment
Table Figure2: Incontinence Devices - Pipeline Products by Segment
Table Incontinence Devices - Pipeline Products by Segment
Incontinence Devices - Pipeline Products by Territory
Table Figure3: Incontinence Devices - Pipeline Products by Territory
Table Incontinence Devices - Pipeline Products by Territory
Incontinence Devices - Pipeline Products by Regulatory Path
Table Figure4: Incontinence Devices - Pipeline Products by Regulatory Path
Table Incontinence Devices - Pipeline Products by Regulatory Path
Incontinence Devices - Pipeline Products by Estimated Approval Date
Table Figure5: Incontinence Devices - Pipeline Products by Estimated Approval Date
Table Incontinence Devices - Pipeline Products by Estimated Approval Date
Table Affluent Medical SASU - Ongoing Clinical Trials Overview
Table Artus - Safety and Clinical Performance Study of the ARTUS Artificial Urinary Sphincter (AUS) for the Treatment of Stress Urinary Incontinence (SUI) Due to Intrinsic Sphincter Deficiency
All India Institute of Medical Sciences Company Overview
All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview
Table All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview
Table Super Hydrophobic Catheter - Product Status
Table Super Hydrophobic Catheter - Product Description
Table Amber-UI Bioelectronic System - Exploratory Safety and Electrophysiological Study of Closed-loop Pudendal Neuromodulation Using an Implantable (Picostim-DyNeuMo) Device in Women with Urinary Incontinence
American Medical Systems Inc Company Overview
American Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table American Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table TOPAS Sling System - Product Status
Table TOPAS Sling System - Product Description
APRUS Bio-Medical Innovations Pvt Ltd Company Overview
Table Levee Medical Inc - Ongoing Clinical Trials Overview
Table Voro Urologic Scaffold - Feasibility Study of A Voro Urologic Scaffold for the Prophylactic Treatment of Post-Prostatectomy Stress Urinary Incontinence
Table Magnetic Endourethral Sphincter - Multicentric Pilot Study for the Application of a Magnetic Endourethral Sphincter for the Treatment of Secondary Stress Urinary Incontinence Damage to the Urethral Sphincter
Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview
Table Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview
Table Permanent Urinary Catheter Shutter - Product Status
Table ACT - A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency
Table ACT - Prospective Study Evaluating the Safety and Effectiveness of Adjustable Continence Therapy (ACT) Balloons for the Management of Urinary Incontinence in Children with Bladder Exstrophy or Incontinent Epispadias
UroMems SAS Company Overview
UroMems SAS Pipeline Products & Ongoing Clinical Trials Overview
Table UroMems SAS Pipeline Products & Ongoing Clinical Trials Overview
Table UroActive - Product Status
Table UroActive - Product Description
Table UroMems SAS - Ongoing Clinical Trials Overview
Table UroActive - Feasibility Study to Assess the URoMems Artificial Urinary Sphincter in the Treatment of Stress Incontinence in Women
Urova Medical Inc. Company Overview
Urova Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table Urova Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Apr 02, 2024: Medline Expands Catheter Portfolio with QiVi MEC Male External Urine Management Device
Mar 19, 2024: Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
Mar 12, 2024: Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatmentof stress urinary incontinence
Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
Mar 08, 2024: Axena Health study shows incontinence is a major burden for women in Kenya and Nigeria
Mar 05, 2024: Axena secures new HCPCS code for Leva Pelvic Health System
Mar 04, 2024: Shenzhen Konmed Technology Receives 510(K) Clearance For Rectal Electrode Probe
Mar 01, 2024: Shenzhen Konmed Technology Receives 510(K) Clearance For Vaginal Electrode Probe
Feb 28, 2024: Covalon to Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024
Feb 28, 2024: Shandong Weigao Group Medical Polymer Announces Preliminary Results for the Year Ended 31 December 2023
Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
Feb 27, 2024: Amber Therapeutics Announces Positive Preliminary Results from its First-in-Human Investigation of Amber-UI, its new Adaptive Implanted Pudendal Neuromodulation System for Urinary Incontinence
Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
Feb 22, 2024: Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call
Feb 22, 2024: Sanofi's Board of Directors Proposes the Appointment of Clotilde Delbos, Anne- Francoise Nesmes and John Sundy as Independent Directors
Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent
Feb 16, 2024: Jim Robo, Former Chairman and CEO of NextEra Energy, to Join Mayo Clinic Board of Trustees
Feb 15, 2024: UroMems Announces Results of First-Ever Smart Artificial Urinary Sphincter Implant in Female Patient to Treat Stress Urinary Incontinence
Feb 09, 2024: Coloplast Announces Interim Financial Report, Q1 2023/24
Feb 08, 2024: ConvaTec Group Receives 510(K) Clearance For GentleCath Air for Women
Feb 08, 2024: Silq Technologies Received Additional 510(K) Clearance For 2-Way 100% Silicone ClearTract Catheter
Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
Feb 07, 2024: Bactiguard Holding Appoints Christine Lind as New CEO
Feb 01, 2024: Sanofi Announces Quarterly Earnings Report and Stock Performance Analysis
Feb 01, 2024: Francois-Xavier Roger Appointed Chief Financial Officer, Member of Sanofi Executive Committee
Feb 01, 2024: Bactiguard Holding Announces Invitation to Presentation of Year-end Report for 2023
Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
Jan 26, 2024: Covalon Announces Management Changes
Jan 23, 2024: Axena Health Commends New Study Showing the Leva System's Long-term Treatment Efficacy for Female Urinary Incontinence
Jan 22, 2024: Axena Health Studies Barriers to First-Line Treatment for Urinary Incontinence
Jan 09, 2024: Axena Health Welcomes 4 Distributors for the Leva Pelvic Health System
Jan 09, 2024: Brian Foard Appointed Head of Specialty Care Global Business Unit, Member of Sanofi Executive Committee
Jan 08, 2024: Pelvital USA Receives Additional 510(K) Clearance For Flyte System
Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
Jan 04, 2024: Covalon Technologies Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO
Dec 13, 2023: Uromems Reaches Significant Milestone: Successful Results in Clinical Feasibility Study of Uroactive Smart Implant for Stress Urinary Incontinence Treatment
Nov 14, 2023: SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
Nov 13, 2023: INVO Reports Record Third Quarter 2023 Financial Results
Nov 09, 2023: Coloplast Reports Annual Report 2022/23
Nov 07, 2023: ProstaLund Announces Interim Report
Nov 07, 2023: AdaptHealth Announces Third Quarter 2023 Results
Nov 05, 2023: Teleflex Reports Third Quarter Financial Results, Full Year 2023 Outlook
Nov 02, 2023: Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member
Oct 27, 2023: Bactiguard Holding Announces Interim Report Q3 2023
Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
Oct 12, 2023: The Exact Onset of the Effect of Botox in Real Time With Use of Our Diary Pod
Oct 10, 2023: HR Pharmaceuticals, Significantly Expands the Trucath Portfolio With Two New Offerings of Ready-To-Use Intermittent Catheters Delivering Optimal Protection, Comfort, and Convenience
Oct 06, 2023: PFD Week Abstracts Show Leva's Long-Term Treatment Value for Female Urinary Incontinence Plus New Data for Other Pelvic Floor Disorders
Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer
Sep 18, 2023: Shandong Weigao Group Medical Polymer Co. Notice of the Third Extraordinary General Meeting
Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources